1. Schering Corporation (59 from 1,829 patents)

2. Pharmacopeia Inc. (4 from 101 patents)

3. Pharmacopeia Drug Discovery, Inc. (2 from 52 patents)

4. Merck Sharp + Dohme Corp. (1 from 2,405 patents)

5. Schering-plough Corporation (1 from 28 patents)

6. Adriano Afonso (0 patent)

7. John J. Baldwin (0 patent)

8. Ge Li (0 patent)

9. Randall R. Rossman (0 patent)

10. Dinanath F. Rane (0 patent)

11. Alan K. Mallams (0 patent)

12. John C. Reader (0 patent)

13. Ronald J. Doll (0 patent)

14. F. George Njoroge (0 patent)

1. 8673924 - Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors

2. 7807683 - N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors

3. 7790474 - p53 modulators

4. 7700773 - 4-cyano, 4-amino, and 4-aminomethyl derivatives of pyrazolo[1,5-a]pyridines, pyrazolo[1,5-c]pyrimidines and 2H-indazole compounds and 5-cyano, 5-amino, and 5-aminomethyl derivatives of imidazo[1,2-a]pyridines, and imidazo[1,5-a]pyrazines as cyclin dependent kinase inhibitors

5. 7635697 - Farnesyl protein transferase inhibitors and methods for treating proliferative diseases

6. 7432268 - 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases

7. 7432265 - Imidazopyrazines as cyclin dependent kinase inhibitors

8. 7161003 - Pyrazolopyrimidines as cyclin dependent kinase inhibitors

9. 7138396 - 17 β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases

10. 7119200 - Pyrazolopyrimidines as cyclin dependent kinase inhibitors

11. 6919341 - Imidazopyrazines as cyclin dependent kinase inhibitors

12. 6903102 - 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases

13. 6800636 - Farnesyl protein transferase inhibitors

14. 6740661 - Farnesyl protein transferase inhibitors

15. 6699872 - N-substituted urea inhibitors of farnesyl-protein transferase